Cost patterns of long-term prescribed medications in patients with multiple sclerosis in Germany

Abstract Multiple sclerosis (MS) is a chronic neurological disease that affects people in their most productive years of life. A multimodal treatment approach is typically employed to slow the progression of disability and alleviate MS-related symptoms. This implies a high financial burden of MS on...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Michael Hecker, Birgit Berger, Niklas Frahm, Felicita Heidler, Bassel Barhoum, Avinash Mohnish Suntah, Finn Brüggemann, Matthias Grothe, Uwe Klaus Zettl
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Nature Portfolio 2025-10-01
Σειρά:	Scientific Reports
Θέματα:	Multiple sclerosis Drug prescriptions Medication costs Germany
Διαθέσιμο Online:	https://doi.org/10.1038/s41598-025-25318-4
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!